Cortical basket cell dysfunction in schizophrenia

Schizophrenia, a debilitating illness affecting 0.51% of the world's population, is characterized by positive, negative and cognitive symptoms. The latter are the best predictor of functional outcome, though largely untreated by current pharmacotherapy; thus a better understanding of the mechanisms underlying cognitive deficits in schizophrenia is crucial. Higher order cognitive processes, such as working memory, are associated with ? (47 Hz) and ? (3080 Hz) oscillations in the prefrontal cortex (PFC), and subjects with schizophrenia exhibit working memory impairments and reduced cortical ? and ? band power. Cortical ? and ? oscillations are dependent on perisomatic inhibition of pyramidal neurons from basket cells expressing cholecystokinin (CCKb cells) and parvalbumin (PVb cells), respectively. Thus, alterations in basket cells may underlie the cortical oscillation deficits and working memory impairments in schizophrenia. Recent findings from postmortem studies suggest that schizophrenia is associated with multiple molecular alterations that regulate signalling from CCKb and PVb cells. These alterations include lower CCK and cannabinoid 1 receptor (CB1R) in CCKb cells, and lower glutamic acid decarboxylase 67 (GAD67) and increased mu opioid receptor (mu OR) in PVb cells, as well as lower GABAA receptor a1 subunit in pyramidal neurons postsynaptic to PVb cells. These changes are thought to lead to increased and decreased strength, respectively, of CCKb and PVb cell-mediated inhibition of postsynaptic pyramidal cells. Therefore, a convergence of evidence suggests a substantial shift in the relative strengths of PFC pyramidal cell inhibition from CCKb and PVb cells that may underlie cortical oscillation deficits and working memory impairments in schizophrenia.